Are we in for a new kind of PrEP? Researchers found that a certain antibiotic showed a 70 percent drop in common STIs.
If approved, ibalizumab will be the first antiretroviral treatment with a new mechanism of action to be approved in nearly a decade.
To mark the kick off of fashion week, we bring you the tale of a 22-year old wunderkind who's created an app that brings poz people together.
A new clinic has become one of the first of its kind to specialize in care for older people living with HIV.
A new drug figured out how to provide long-acting HIV defense — with as little as one to two doses a year!
Diehard academic types might be surprised to see My Brother's Keeper and others on this list.
Scientists are trying to figure out what makes HIV strong enough to break through our body's immune system.